IRADIMED CORP - Common Stock (IRMD)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Number of holders
27
Total 13F shares, excl. options
1,459,156
Shares change
-41,978
Total reported value, excl. options
$14,010,010
Value change
-$339,474
Number of buys
7
Number of sells
-22
Price
$9.6

Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2017

37 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2017.
IRADIMED CORP - Common Stock (IRMD) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,459,156 shares of 12,733,410 outstanding shares and own 11.46% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (456,810 shares), Mondrian Investment Partners LTD (206,547 shares), VANGUARD GROUP INC (175,425 shares), Granite Investment Partners, LLC (99,238 shares), AQR CAPITAL MANAGEMENT LLC (93,275 shares), MENTA CAPITAL LLC (70,276 shares), Spark Investment Management LLC (45,785 shares), BlackRock Inc. (42,540 shares), MORGAN STANLEY (39,976 shares), and FEDERATED INVESTORS INC /PA/ (39,606 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.